The Journal of Infectious Diseases · 2002 · 427 citations · 37 references
Veterinary MedicineImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityImmune Responses To InfectionInfectious Disease PathophysiologyInnate Immune ResponseInnate Immune Signaling PathwaysPulmonary InfectionsRespiratory Infectious DiseasesAntagonist ActivityAntagonist InteractionsCompetitive Receptor InteractionsInfluenza PneumoniaPlatelet Receptor SignalingPlatelet-activating Factor SignalingReceptor-mediated InteractionsSynergism Mechanisms
A lethal synergism exists between influenza virus and pneumococcus, which likely accounts for excess mortality from secondary bacterial pneumonia during influenza epidemics. Characterization of a mouse model of synergy revealed that influenza infection preceding pneumococcal challenge primed for pneumonia and led to 100% mortality. This effect was specific for viral infection preceding bacterial infection, because reversal of the order of administration led to protection from influenza and improved survival. The hypothesis that influenza up-regulates the platelet-activating factor receptor (PAFr) and thereby potentiates pneumococcal adherence and invasion in the lung was examined in the model. Groups of mice receiving CV-6209, a competitive antagonist of PAFr, had survival rates similar to those of control mice, and lung and blood bacterial titers increased during PAFr inhibition. These data suggest that PAFr-independent pathways are operative in the model, prompting further study of receptor interactions during pneumonia and bacteremia. The model of lethal synergism will be a useful tool for exploring this and other mechanisms underlying viral-bacterial interactions.
37
Principles and Practice of Infectious Diseases.
Annals of Internal Medicine · 1991 · 12.1K citations
Options for the control of influenza III
Gordon Ada, Gregory A. Tannock, Alan Hampson · Vaccine · 1997 · 587 citations
Medicine, Infectious Disease Control, Infectious Diseases +12